There has been a rise in the number of cases related to blood disorders. Also known as hematologic diseases basically affecting the blood and the blood forming organs. These diseases include complications from transfusions, chemotherapy treatments, sickle cell disease, HIV, Anemia and certain rare genetic disorders. People often are shocked about the reports revealing such unexpected cases of Anemia. It becomes necessary to expand the Understanding and awareness of different types of Anemia and preparing to tackle it collectively.
Let’s Explore the Facts of Hemolytic Anemia in Detail for better understanding
Hemolysis, the aberrant destruction of red blood cells, either in the blood vessels or elsewhere in the human body, causes hemolytic anemia, also known as hemolytic anaemia. Though it can also happen mechanically or in the reticuloendothelial system, this most frequently happens in the spleen. A condition known as hemolytic anemia occurs when the body breaks down red blood cells more quickly than they can be produced. Hemolysis is the breakdown of red blood cells.
Every component of your body receives oxygen from red blood cells. You have anemia if your red blood cell count is below normal. Your blood cannot adequately oxygenate all of your tissues and organs when you have anemia.
Your body cannot function as efficiently as it should if it does not receive adequate oxygen.There are two types of hemolytic anemia: inherited and acquired. When parents give their offspring the gene for hemolytic anemia, the disorder is known as inherited hemolytic anemia.
In the hereditary form, the condition’s genes are passed on from parents to their offspring. Thalassemia and sickle cell anemia are two prevalent causes of this kind of anemia. Red blood cells produced by these disorders have a shorter lifespan than healthy red blood cells.
Read More: https://arabinsightscare.com/understanding-the-actual-reality-of-hemolytic-anemia/
Cancer Care has become a major industry with a three-digit billion dollar market size wherein big pharma and medical companies are on top.
Good diagnostics with respect to early detection and correct stratification are most certainly part of a notable solution.But the reality of cancer diagnostic tests is that it is not being up to the task.
He is setting a benchmark through his consistent efforts in cell separation and diagnostic test development.Basically, he wanted to develop assays in the field of general magnetic particle-based cell separation technology.
At that time the start-up managed to raise funds by making a pitch at the Y-combinator in the US at the end of 2014.However, the team lost its cohesive approach towards the work.
This marked the intent to commercialize one invention and was reason enough for his current partners to be on board for kick-starting the project, later called SanoLiBio.A Life-changing ProjectSanoLiBio is a german based start-up that is focused on the enrichment of rare cells in general and circulating tumor cells (CTCs) in particular taken from the liquid biopsy.
This Medtech start-up is currently at an infant stage in the liquid biopsy industry.
